Keyphrases
Natural Killer Cells
88%
Engager
51%
Interleukin-15 (IL-15)
31%
Trispecific
22%
Natural Killer Cell Activity
18%
Ovarian Cancer
12%
Human NK Cells
11%
Metabolic Programming
11%
B7-H3
11%
Antitumor Activity
11%
CD16
11%
N-803
10%
Activating Receptors
9%
Cell Proliferation
8%
Tumor
7%
Hypoxia
7%
T Cells
7%
Solid Tumors
7%
ScFv
7%
Ovarian Cancer Cells
6%
Human Ovarian Cancer
6%
Cytokine Production
6%
Programmed Death-ligand 1 (PD-L1)
6%
Myeloid-derived Suppressor Cells
6%
Cytotoxicity
6%
TriKE
5%
Inhibitory Receptors
5%
AT-rich
5%
Continuous Treatment
5%
Minichromosome Maintenance Proteins
5%
Lung Cancer
5%
Low Density
5%
Induced Pluripotent Stem Cells (iPSCs)
5%
Reconstitution
5%
Cytolytic Activity
5%
Metabolic Defects
5%
Mesothelin
5%
Myelodysplastic Syndrome
5%
NK Cell Exhaustion
5%
Interaction Domains
5%
Cell Targeting
5%
PD-1 Expression
5%
Transplantation
5%
TEM8
5%
Genome Stability
5%
Rich Interaction
5%
Tumor Stroma
5%
Human Epidermal Growth Factor Receptor 2 (HER2)
5%
Proliferative Activity
5%
Chronic Lymphocytic Leukemia
5%
Immunology and Microbiology
Natural Killer Cell
100%
Interleukin 15
25%
Cell Function
18%
Immunotherapy
18%
Cytotoxicity
18%
In Vitro
16%
Cytokine
13%
Antineoplastic Activity
11%
CD16
11%
Cancer Cell
10%
T Cell
9%
Myeloid-Derived Suppressor Cell
6%
Immune Checkpoint Blockade
5%
Stroma
5%
CD19
5%
Mesothelin
5%
Induced Pluripotent Stem Cell
5%
Genomic Instability
5%
Minichromosome
5%
Prostate Specific Membrane Antigen
5%
Human Immunodeficiency Virus
5%
Neck
5%
Cytokine Production
5%
Medicine and Dentistry
Natural Killer Cell
48%
Ovarian Cancer
12%
Interleukin 15
11%
Prostate Cancer
11%
Cytotoxicity
10%
In Vitro
9%
Cancer Cell
8%
Immunotherapy
6%
Superagonist
6%
Cell Function
6%
Antineoplastic Activity
6%
Solid Malignant Neoplasm
5%
Cytokine
5%
Lung Cancer
5%
Mesothelin
5%
Immune Checkpoint Blockade
5%
Non Small Cell Lung Cancer
5%
Prostate Specific Membrane Antigen
5%
Human Immunodeficiency Virus
5%
Lymph Duct
5%
Head and Neck Cancer
5%
